Replies to post #1960 on Synergy Pharmaceuticals Inc fka SGYPQ

[iandy]

>In addition, Synergy has already completed patient recruitment for the two double-blind placebo-controlled phase 3 clinical trials with plecanatide in IBS-C and remains on-track to report top-line data from both trials in the fourth quarter of this year.<

Is this the first time they announced full enrollment in the IBS-C trials?